Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 2
1969 1
1970 1
1973 1
1974 3
1975 1
1976 2
1977 2
1978 4
1980 2
1981 3
1982 8
1983 1
1984 5
1985 6
1986 9
1987 2
1988 15
1989 15
1990 17
1991 26
1992 38
1993 51
1994 67
1995 65
1996 89
1997 79
1998 138
1999 190
2000 227
2001 297
2002 417
2003 501
2004 675
2005 829
2006 1059
2007 1158
2008 1236
2009 1332
2010 1346
2011 1410
2012 1497
2013 1540
2014 1750
2015 1789
2016 1702
2017 1691
2018 1837
2019 1784
2020 2057
2021 2156
2022 2002
2023 1896
2024 793

Text availability

Article attribute

Article type

Publication date

Search Results

29,869 results

Results by year

Filters applied: . Clear all
Page 1
Inflammation and atherosclerosis: signaling pathways and therapeutic intervention.
Kong P, Cui ZY, Huang XF, Zhang DD, Guo RJ, Han M. Kong P, et al. Signal Transduct Target Ther. 2022 Apr 22;7(1):131. doi: 10.1038/s41392-022-00955-7. Signal Transduct Target Ther. 2022. PMID: 35459215 Free PMC article. Review.
Atherosclerosis is a chronic inflammatory vascular disease driven by traditional and nontraditional risk factors. ...Herein, we summarize the knowledge on cellular participants and key inflammatory signaling pathways in atherosclerosis, and discuss the preclinical s
Atherosclerosis is a chronic inflammatory vascular disease driven by traditional and nontraditional risk factors. ...Herein, we summa
Research Progress on the Relationship between Atherosclerosis and Inflammation.
Zhu Y, Xian X, Wang Z, Bi Y, Chen Q, Han X, Tang D, Chen R. Zhu Y, et al. Biomolecules. 2018 Aug 23;8(3):80. doi: 10.3390/biom8030080. Biomolecules. 2018. PMID: 30142970 Free PMC article. Review.
Atherosclerosis-related inflammation is mediated by proinflammatory cytokines, inflammatory signaling pathways, bioactive lipids, and adhesion molecules. This review discusses the effects of inflammation and the systemic inflammatory signaling pathway on a
Atherosclerosis-related inflammation is mediated by proinflammatory cytokines, inflammatory signaling pathways, bioactive lipi
Immunity and Inflammation in Atherosclerosis.
Wolf D, Ley K. Wolf D, et al. Circ Res. 2019 Jan 18;124(2):315-327. doi: 10.1161/CIRCRESAHA.118.313591. Circ Res. 2019. PMID: 30653442 Free PMC article. Review.
There is now overwhelming experimental and clinical evidence that atherosclerosis is a chronic inflammatory disease. Lessons from genome-wide association studies, advanced in vivo imaging techniques, transgenic lineage tracing mice, and clinical interventional studies have …
There is now overwhelming experimental and clinical evidence that atherosclerosis is a chronic inflammatory disease. Lessons from gen …
Atherosclerosis and inflammation. New therapeutic approaches.
Pedro-Botet J, Climent E, Benaiges D. Pedro-Botet J, et al. Med Clin (Barc). 2020 Sep 25;155(6):256-262. doi: 10.1016/j.medcli.2020.04.024. Epub 2020 Jun 20. Med Clin (Barc). 2020. PMID: 32571617 Review. English, Spanish.
Hence, innate and adaptive immune responses play an important role in the onset and progression of atherosclerosis. More recently, some clinical studies were designed to address the impact of anti-inflammatory intervention strategies in reducing risk of cardiovascular dise …
Hence, innate and adaptive immune responses play an important role in the onset and progression of atherosclerosis. More recently, so …
Targeting inflammation in atherosclerosis - from experimental insights to the clinic.
Soehnlein O, Libby P. Soehnlein O, et al. Nat Rev Drug Discov. 2021 Aug;20(8):589-610. doi: 10.1038/s41573-021-00198-1. Epub 2021 May 11. Nat Rev Drug Discov. 2021. PMID: 33976384 Free PMC article. Review.
Atherosclerosis, a dominant and growing cause of death and disability worldwide, involves inflammation from its inception to the emergence of complications. Targeting inflammatory pathways could therefore provide a promising new avenue to prevent and treat athero
Atherosclerosis, a dominant and growing cause of death and disability worldwide, involves inflammation from its inception to t
Atherosclerosis and inflammation: overview and updates.
Geovanini GR, Libby P. Geovanini GR, et al. Clin Sci (Lond). 2018 Jun 21;132(12):1243-1252. doi: 10.1042/CS20180306. Print 2018 Jun 29. Clin Sci (Lond). 2018. PMID: 29930142 Review.
The concept that inflammation participates pivotally in the pathogenesis of atherosclerosis and its complications has gained considerable attention, but has not yet entered clinical practice. ...For example, mononuclear phagocytes contribute to all stages of this di …
The concept that inflammation participates pivotally in the pathogenesis of atherosclerosis and its complications has gained c …
The Diabetes Mellitus-Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation.
Poznyak A, Grechko AV, Poggio P, Myasoedova VA, Alfieri V, Orekhov AN. Poznyak A, et al. Int J Mol Sci. 2020 Mar 6;21(5):1835. doi: 10.3390/ijms21051835. Int J Mol Sci. 2020. PMID: 32155866 Free PMC article. Review.
Chronic inflammation is currently considered as one of the key factors in atherosclerosis development and is present starting from the earliest stages of the pathology initiation. ...In this review, we summarize the main aspects of diabetes mellitus that possibly af …
Chronic inflammation is currently considered as one of the key factors in atherosclerosis development and is present starting …
Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities.
Bäck M, Yurdagul A Jr, Tabas I, Öörni K, Kovanen PT. Bäck M, et al. Nat Rev Cardiol. 2019 Jul;16(7):389-406. doi: 10.1038/s41569-019-0169-2. Nat Rev Cardiol. 2019. PMID: 30846875 Free PMC article. Review.
Atherosclerosis is a lipid-driven inflammatory disease of the arterial intima in which the balance of pro-inflammatory and inflammation-resolving mechanisms dictates the final clinical outcome. ...One of the major effects of inflammation resolution mediators
Atherosclerosis is a lipid-driven inflammatory disease of the arterial intima in which the balance of pro-inflammatory and inflamm
Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions.
Raggi P, Genest J, Giles JT, Rayner KJ, Dwivedi G, Beanlands RS, Gupta M. Raggi P, et al. Atherosclerosis. 2018 Sep;276:98-108. doi: 10.1016/j.atherosclerosis.2018.07.014. Epub 2018 Jul 25. Atherosclerosis. 2018. PMID: 30055326 Review.
Rudolph Virchow (1821-1902) recognized inflammation in histological preparations of coronary arteries and proposed that inflammation plays a causal role in atherosclerosis. ...In this article, we review the pathophysiologic contribution of inflammation
Rudolph Virchow (1821-1902) recognized inflammation in histological preparations of coronary arteries and proposed that inflammati
Atherosclerosis and Inflammation: Insights from the Theory of General Pathological Processes.
Gusev E, Sarapultsev A. Gusev E, et al. Int J Mol Sci. 2023 Apr 26;24(9):7910. doi: 10.3390/ijms24097910. Int J Mol Sci. 2023. PMID: 37175617 Free PMC article. Review.
In this review, we analyze various typical phenomena and outcomes of cellular pro-inflammatory stress in atherosclerosis, as well as the role of endothelial dysfunction in local and systemic manifestations of low-grade inflammation. ...In summary, atherosclerosis
In this review, we analyze various typical phenomena and outcomes of cellular pro-inflammatory stress in atherosclerosis, as well as …
29,869 results
You have reached the last available page of results. Please see the User Guide for more information.